- NCBI Gene Id:
- Protein Name:
- Connective tissue growth factor
- Alias Symbols:
- CCN2, NOV2, HCS24, IGFBP8, MGC102839, CTGF
- Replacement Item:
- This antibody may replace item sc-101586 from Santa Cruz Biotechnology.
- Description of Target:
- RABBIT ANTI HUMAN CTGF
- Protein Size (# AA):
- ELISA, WB
- Tissue Tool:
- Find tissues and cell lines supported by DNA array analysis to express CTGF.
- RNA Seq:
- Find tissues and cell lines supported by RNA-seq analysis to express CTGF.
- The immunogen for anti-CTGF antibody: recombinant human CTGF.
- Predicted Species Reactivity:
- Predicted Homology Based on Immunogen Sequence:
- Product Format:
- Purified IgG - lyophilised
- Reconstitution and Storage:
- Reconstitution: Reconstitute with 0.1ml distilled water. For long term storage the addition of 0.09% sodium azide is recommended. NB: For functional studies do not add azide.
Storage: Prior to reconstitution store at +4oC.
After reconstitution store at -20oC.
Storage in frost-free freezers is not recommended. This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- Printable datasheet for anti-CTGF antibody - OASA07649
- Polyclonal IgG
- Application Info:
- This product requires antigen retrieval using heat treatment prior to staining of paraffin sections. Sodium citrate buffer pH 6.0 is recommended for this purpose.
- Preservative Stabilisers: None present
Antiserum Preparation: Antisera to human CTGF were raised by repeated immunisations of rabbits with highly purified antigen. Purified IgG was prepared from whole serum by affinity chromatography.
- Approx Protein Conc: IgG concentration 1.0mg/ml after reconstitution.
Buffer Solutions: Phosphate buffered saline pH7.2
- Target Reference:
- 1. Moussad, E.E-D.A. and Brigstock, D.R. (2000) Connective tissue growth factor: What 's in a name? Mol. Genet. Metab. 71: 276-292.
2. Westermann, D. et al. (2009) Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy. Diabetes. 58:1373-81.